We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Potential Cost of Data Breaches of Protected Health Information Could Reach USD 5.6 Billion Annually

By MedImaging International staff writers
Posted on 13 Jan 2015
The healthcare industry and institutions face an ever-increasing threat of data breaches to clinical and patient information.

Cybercriminals are attracted to Protected Health Information (PHI) such as Social Security Numbers (SSN) on Medicare cards, and other sensitive medical information stored online on an institutions' network, or in the cloud. Many healthcare institutions, such as doctor’s clinics, do not have the resources to secure such information adequately.

Healthcare data breaches are expected to surge with increased adoption of Electronic Medical Records (EMRs), and wearable healthcare technologies. The annual cost of data breaches is also increasing and healthcare institutions will need to invest much more in data security to protect their credibility as an institution toward all their stakeholders.

According to the Reuters news agency (New York, USA), the United States Federal Bureau of Investigation (FBI; Washington DC, USA) has issued a private notice to the healthcare industry, warning healthcare providers to better secure their data. The notice states “The healthcare industry is not as resilient to cyber-intrusions compared to financial and retail sectors, therefore the possibilities of increased cyber-intrusions is likely.”

Related Links:

Reuters News Agency
FBI


Mobile X-Ray System
K4W
Digital Color Doppler Ultrasound System
MS22Plus
Biopsy Software
Affirm® Contrast
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.